When to reinvite initially ineligible populations for targeted lung cancer screening?

BMJ Open Respir Res. 2024 May 15;11(1):e002193. doi: 10.1136/bmjresp-2023-002193.

Abstract

Introduction: Targeted low-dose CT lung cancer screening reduces lung cancer mortality. England's Targeted Lung Health Check programme uses risk prediction tools to determine eligibility for biennial screening among people with a smoking history aged 55-74. Some participants initially ineligible for lung cancer screening will later become eligible with increasing age and ongoing tobacco exposure. It is, therefore, important to understand how many people could qualify for reinvitation, and after how long, to inform implementation of services.

Methods: We prospectively predicted future risk (using Prostate, Lung, Colorectal and Ovarian trial's risk model (PLCOm2012) and Liverpool Lung Project version 2 (LLPv2) risk models) and time-to-eligibility of 5345 participants to estimate how many would become eligible through the course of a Lung Health Check screening programme for 55-74 years.

Results: Approximately a quarter eventually become eligible, with those with the lowest baseline risks unlikely to ever become eligible. Time-to-eligibility is shorter for participants with higher baseline risk, increasing age and ongoing smoking status. At a PLCOm2012 threshold ≥1.51%, 68% of those who continue to smoke become eligible compared with 18% of those who have quit.

Discussion: Predicting which participants may become eligible, and when, during a screening programme can help inform reinvitation strategies and service planning. Those with risk scores closer to the eligibility threshold, particularly people who continue to smoke, will reach eligibility in subsequent rounds while those at the lowest risk may be discharged from the programme from the outset.

Keywords: Clinical Epidemiology; Lung Cancer; Mass Screening.

MeSH terms

  • Aged
  • Early Detection of Cancer* / methods
  • Eligibility Determination
  • England / epidemiology
  • Female
  • Humans
  • Lung Neoplasms* / diagnosis
  • Male
  • Mass Screening / methods
  • Middle Aged
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Smoking / adverse effects
  • Smoking / epidemiology
  • Tomography, X-Ray Computed